Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis

Summary Background Recent evidence assigns the vitronectin receptors (VnRs) an important role in regulating tumour cell invasion and dissemination. In vivo and in vitro studies document that all trans‐retinoid acids (ATRAs) inhibit growth‐inducing apoptosis in melanomas. Objectives We have analysed...

Full description

Saved in:
Bibliographic Details
Published in:British journal of dermatology (1951) 2003-03, Vol.148 (3), p.424-433
Main Authors: Baroni, A., Paoletti, I., Silvestri, I., Buommino, E., Carriero, M.V.
Format: Article
Language:English
Subjects:
all-trans retinoic acid
Antineoplastic Agents - pharmacology
Apoptosis
Biological and medical sciences
Blotting, Western - methods
cell adhesion
Cell Adhesion - drug effects
cell migration
Cell Movement - drug effects
Cytoskeleton - drug effects
Dermatology
DNA, Neoplasm - analysis
Down-Regulation - drug effects
Humans
Integrin alphaVbeta3 - metabolism
M14 cells
Medical sciences
melanoma
Melanoma, Experimental - metabolism
Neoplasm Proteins - metabolism
Precipitin Tests
Tretinoin - pharmacology
Tumor Cells, Cultured - drug effects
Tumors of the skin and soft tissue. Premalignant lesions
vitronectin receptor
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background Recent evidence assigns the vitronectin receptors (VnRs) an important role in regulating tumour cell invasion and dissemination. In vivo and in vitro studies document that all trans‐retinoid acids (ATRAs) inhibit growth‐inducing apoptosis in melanomas. Objectives We have analysed the effects of ATRA treatment on melanoma cell adhesion and motility. Methods Human M14 melanoma cells were treated with 10 µmol L−1 ATRA for different times and stained with rhodamine–phalloidin to analyse the effect of treatment on cytoskeleton organization. Cell adhesion and cell migration assays were performed to analyse the role of VnRs in the ATRA‐induced early stages of apoptosis. VnR expression was evaluated by Western blot, immunoprecipitation and immunocytochemistry assays. Results First, using an annexin V assay, we found that apoptosis was triggered by 48 h with 10 µmol L−1 ATRA exposure. At this time point, decrease in the F‐actin polymerization as well as inhibition of cell adhesive ability to vitronectin (Vn) was exerted by ATRA treatment. In the presence of serum, exposure to 10 µmol L−1 ATRA for 48 h produced a dramatic inhibition of the cell adhesion ability that was comparable with that exerted by untreated cells preincubated with anti‐αvβ3 or anti‐αvβ5 VnR monoclonal antibodies. Functionally, the treatment of melanoma cells with 10 µmol L−1 ATRA for 48 h causes an inhibition of directional cell migration towards Vn‐coated filters. Therefore, we analysed the effect of ATRA on the VnR expression. Both αvβ3 and αvβ5 VnR levels were reduced upon exposure to 10 µmol L−1 ATRA for 48 h as shown by Western blot, immunoprecipitation and immunocytochemistry assays. Conclusions Altogether, our data indicate that treatment of M14 melanoma cells with ATRA downregulates VnR expression and that this reduction is closely correlated with the ATRA‐dependent inhibition of actin‐fibre organization, cell adhesion and migration. Although the mechanism by which ATRA regulates the expression of VnR in M14 melanoma cells needs further elucidation, this system may represent a model for understanding the molecular basis of ATRA therapy in melanoma.
ISSN:0007-0963
1365-2133
DOI:10.1046/j.1365-2133.2003.05165.x